AI Analysis AI Analysis of PASG AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PASG to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Passage Bio, Inc. stock price down 1.63% on Friday
(Updated on Jul 17, 2026)

Sell candidate since Jun 25, 2026 Gain 11.55%

The Passage Bio, Inc. stock price fell by -1.63% on the last day (Friday, 17th Jul 2026) from $4.91 to $4.83. During the last trading day the stock fluctuated 4.91% from a day low at $4.68 to a day high of $4.91. The price has fallen in 6 of the last 10 days but is still up by 3.21% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -21 thousand shares and in total, 55 thousand shares were bought and sold for approximately $267.32 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -8.63% during the next 3 months and, with a 90% probability hold a price between $3.32 and $5.45 at the end of this 3-month period.

PASG Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, June 25, 2026, and so far it has risen 11.55%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Passage Bio, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $5.24. On a fall, the stock will find some support from the short-term average at $4.69. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Passage Bio, Inc. stock

Passage Bio, Inc. finds support from accumulated volume at $4.70 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.230 between high and low, or 4.91%. For the last week the stock has had daily average volatility of 7.34%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PASG) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Passage Bio, Inc. to open at $4.81, and during the day (based on 14 day Average True Range), to move between $4.62 and $5.04, which gives a possible trading interval of +/-$0.413 (+/-8.93%) up or down from last closing price. If Passage Bio, Inc. takes out the full calculated possible swing range there will be an estimated 8.93% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.70 (2.69%) than the resistance at $5.03 (4.14%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Passage Bio, Inc. stock A Buy?

Passage Bio, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.871 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 20, 2026 - $4.81 ( 0.483%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PASG Performance

Trading levels for PASG

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 5.04 4.28%
R2 4.95 2.46%
R1 4.89 1.34%
Price 4.83
S1 4.72 -2.30%
S2 4.66 -3.43%
S3 4.58 -5.24%

Accumulated Volume Support & Resistance Levels

Level Price
R3 5.88 21.74%
R2 5.71 18.22%
R1 5.03 4.14%
Price 4.83
S1 4.70 -2.69%
S2 4.33 -10.35%
S3 4.12 -14.70%

FAQ

What is the symbol for Passage Bio, Inc. Stock and on which exchange is it traded?
The symbol for Passage Bio, Inc. is PASG and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Passage Bio, Inc. Stock?
Passage Bio, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Passage Bio, Inc. Stock?
Passage Bio, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Passage Bio, Inc. Stock.

What's the current price of Passage Bio, Inc. Stock?
As of the end of day on the Jul 17, 2026, the price of an Passage Bio, Inc. (PASG) share was $4.83.

What is the 52-week high and low for Passage Bio, Inc. Stock?
The 52-week high for Passage Bio, Inc. Stock is $20.00 and the 52-week low is $3.29.

What is the market capitalization of Passage Bio, Inc. Stock?
As of the Jul 17, 2026, the market capitalization of Passage Bio, Inc. is 15.775M.

When is the next earnings date for Passage Bio, Inc.?
The upcoming earnings date for Passage Bio, Inc. is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT PASSAGE BIO, INC.
Passage Bio
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 capsid to deliver to the brain a functional granulin (GRN) and gene encoding progranulin (PGRN) for the...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
0.578% Jul 13
SRPT
$17.02
1.18% Jun 29
JLL
$299.78
10.30% Jun 24
NMRK
$15.02
3.86% Jun 24
CAG
$13.43
6.29% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE